Shingles vaccine found to cut dementia risk by 20%

a year ago

Shingles vaccine reduces dementia risk by 20%, according to a new study.
The study utilized a unique public health policy in Wales to compare vaccinated and unvaccinated groups.
Herpesviruses, including shingles, may play a role in Alzheimer’s disease development.
The research found no significant differences in other health factors between the groups, strengthening the vaccine's link to reduced dementia risk.
Women benefited more from the vaccine than men, possibly due to stronger immune responses.
Experts highlight the need for further research to confirm causality but acknowledge the promising findings.
The study was published in the journal Nature.

Hasty Briefsbeta